The MHRA pharmacovigilance inspection programme: priorities and challenges

被引:0
|
作者
Adams, Anna L. [1 ]
Trevett, Kiernan [1 ]
机构
[1] Med & Healthcare Prod Regulatory Agcy, 10 South Colonnade, London E14 4PU, England
关键词
D O I
10.1177/2042098619875317
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [1] The MHRA inspection: our experiences
    Wilson, S. J.
    Bellamy, M. C.
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 2007, 98 (02) : 284P - 284P
  • [3] Pharmacovigilance programme of India
    Vivekanandan, Kalaiselvan
    Prakash, Jai
    Singh, Gyanendra Nath
    [J]. ARCHIVES OF PHARMACY PRACTICE, 2012, 3 (03) : 229 - 232
  • [4] Challenges in pharmacovigilance
    Dikshit, R. K.
    [J]. INDIAN JOURNAL OF PHARMACOLOGY, 2010, 42 (06) : 333 - 333
  • [5] Strengthening the Pharmacovigilance Programme in Nepal
    Santosh, K. C.
    Tragulpiankit, P.
    Gorsanan, P.
    Edwards, I. R.
    Alam, K.
    [J]. NEPAL JOURNAL OF EPIDEMIOLOGY, 2013, 3 (01): : 230 - 235
  • [6] Pharmacovigilance programme in emergencies room
    Quijada Manuitt, Maria Angeles
    Castillo Ocana, Marta
    Delgado Espinoza, Claudia
    Garrido Sanchez, Maite
    Antonijoan, Rosa
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 : 50 - 50
  • [7] An update on the Pharmacovigilance Programme of India
    Lihite, Ratan J.
    Lahkar, Mangala
    [J]. FRONTIERS IN PHARMACOLOGY, 2015, 6
  • [8] Shifting Inspection Priorities
    Wechsler, Jill
    [J]. Pharmaceutical Technology, 2001, 25 (03): : 16 - 24
  • [10] MHRA bans valproate prescribing for women not in pregnancy prevention programme
    Iacobucci, Gareth
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2018, 361